Skip to main content


Volume 2 Supplement 1


  • Poster presentation
  • Open Access

0097. Myeloid-derived suppressor cells attenuate inflammation and improve the survival of microbial sepsis

  • 1,
  • 1 and
  • 1
Intensive Care Medicine Experimental20142 (Suppl 1) :P9

  • Published:


  • Dendritic Cell
  • Inflammatory Condition
  • Myeloid Cell
  • Heterogeneous Population
  • Lavage Fluid


Myeloid-derived suppressor cells (MDSCs) are heterogeneous population of immature myeloid cells with suppressive activity, containing precursor of granulocytes, macrophages, and dendritic cells [13]. They expand in inflammatory conditions and regulate immune responses. However, the role that MDSCs played in other chronic or acute inflammatory conditions like sepsis is not well understood.


To find the role of MDSCs in sepsis and their relationship with the inflammatory cytokines.


The model of caecal ligation and puncture (CLP) was used to induce polymicrobial sepsis in adult male BALB/c mice. Mice were killed under anesthesia, then blood, peritoneal lavage fluid, and organs were harvested. After the spleen MDSCs were isolated, 30 BALB/c mice were randomized divided into three groups which were CLP+MDSCs (day3),CLP+MDSCs (day 10), CLP+saline whereas MDSCs were adoptive transferred into these mice respectively. And the MDSCs accumulation in spleen were observed at day1,3,6,10.


MDSCs progressively accumulated in spleens during sepsis in survived mice. They were increasing from ~8% at day 1 to ~50% at day 10. Adoptive transfer of late MDSCs into naïve mice after CLP could increase the level of IL-10, decrease the level of INF-γ, and improve the survival rate.


MDSCs could influence the inflammation response after CLP. Contrasting with the deleterious role of MDSCs in tumor associated diseases, the protective role of these cells was appeared during the early period of polymicrobial sepsis. This may provide a new direction for the treatment of sepsis.


Grant acknowledgement

We thank to the staff members of the department of SICU of the First Affiliated Hospital, Sun Yat-sen University.

Authors’ Affiliations

The 1st Affiliated Hospital, Sun Yat-Sen University, Surgical Intensive Care Unit, Guangzhou, China


  1. Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H: The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007,67(1):425. author reply 426 10.1158/0008-5472.CAN-06-3037PubMed CentralPubMedView ArticleGoogle Scholar
  2. Poschke I, Kiessling R: On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol 2012,144(3):250–268. 10.1016/j.clim.2012.06.003PubMedView ArticleGoogle Scholar
  3. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology 2009,9(3):162–174. 10.1038/nri2506PubMed CentralPubMedView ArticleGoogle Scholar


© Tong et al; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.